24-Sep-2009 - The European Commission has approved Novartis’ €925m ($1.2bn) acquisition of Ebewe Spezial-Pharma’s generic injectables business.
23-Sep-2009 - Israeli generics giant Teva Pharmaceutical Industries will close one of its manufacturing plants in the Czech Republic by the end of the year, resulting in the loss of around 400 jobs.
21-Sep-2009 - Apotex’s manufacturing difficulties have begun to impact on its operations, with the company recalling some products, New Zealand authorities issuing a temporary import ban and lay offs at a supplier.
21-Sep-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at Sanofi-Aventis, MorphoSys and Ironwood Pharmaceuticals.
17-Sep-2009 - US biotechnology major Genzyme has begun $68m of refurbishment work on a new 211,000 sgft manufacturing and shipping complex in Northborough, Massachusetts.
16-Sep-2009 - Bristol-Myers Squibb (B-MS) is continuing to sell divisions, with the latest deal offloading its Indonesian unit and product rights to Japan-based Taisho Pharmaceutical for $310m (€211m).
16-Sep-2009 - The FDA has approved four H1N1 vaccines, made by CSL, AstraZeneca, Novartis and Sanofi-Aventis, that will be distributed in the next four weeks as part of the US’ swine flu preparation.
15-Sep-2009 - US drugmaker Eli Lilly plans to cut 5,500 jobs by 2011 as it prepares to enter what CEO John Lechleiter said will be “the most challenging period in [the] company’s history.”
15-Sep-2009 - GlaxoSmithKline (GSK) must hand over emails from researchers studying birth defects allegedly caused by Paxil (paroxetine) after a district judge refused to block a family’s request to see the documents.
14-Sep-2009 - UK pharmaceutical major AstraZeneca will eliminate 133 US drug manufacturing jobs in response to increasing market competition for its asthma treatment Pulmicort Respulses.
14-Sep-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Roche appointing Genentech’s CEO to lead its pharma division and Mylan’s CFO leaving after three months in the job.
10-Sep-2009 - Last week, US pharmaceuticals giant Pfizer agreed to pay $2.3bn to resolve criminal and civil liability relating to the off-label promotion of several of its drugs in what the Department of Justice called the largest fraud settlement in its history.
10-Sep-2009 - More than 50 per cent of executives believe their company fails to respond quickly enough to pandemics because of lapses in the supply chain, according to an IBM survey.
09-Sep-2009 - Sanofi Aventis says it has been contracted to supply the Brazilian government with up to 33 million doses of H1N1 “swine” flu.
08-Sep-2009 - Pharmaceutical manufacturer Galencia says its acquisition of Switzerland-based biotech group OM Pharma will bolster its international presence.
07-Sep-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma space, including Merck’s post-merger management structure and a difference of opinion at LifeCycle Pharma.
03-Sep-2009 - Japanese drugmaker Dainippon Sumitomo Pharma (DSP) has entered into a definitive agreement to acquire US pharmaceutical group Sepracor for $2.6bn (€1.8bn).
03-Sep-2009 - The biosimilars sector is predicted to be worth $19.4bn (€13.6bn) by 2014, by which time the US will have overtaken Asia as the dominant market, according to a report.
02-Sep-2009 - The EMEA has issued US biotech firm Genzyme with a letter detailing “one major observation and several other observations” following an inspection of its Allston, Massachusetts manufacturing plant last month.
02-Sep-2009 - In the next week the Chinese SFDA is expected to approve licences for two locally produced H1N1 vaccines, which unlike some alternatives only require one dose to confer immunity.
01-Sep-2009 - Sanofi-aventis is initiating the phased closing its manufacturing facility in Kansas, US, with complete shutdown expected to occur in 2012 and impact on 370 employees.
31-Aug-2009 - Basel-headquartered Roche has paid fellow Swiss firm Lonza $290m (€203m) for its Singapore biologics plant in a bid to secure long-term manufacturing capacity for biotech cancer drugs.
31-Aug-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Novartis’ former CEO joining Amylin’s board and an appointment at OctoPlus.
26-Aug-2009 - Europe is pulling ahead of the US in research productivity, according to a controversial new study by Washington public policy think tank Health Affairs.
26-Aug-2009 - Pfizer’s new $214.8 million (€150m) biotechnology facility in Strangnas, Sweden was inaugurated yesterday, securing the country’s future in the company’s manufacturing network according to global manufacturing president Natale Ricciardi.